Skip to search formSkip to main contentSkip to account menu

XP13512

Known as: XP 13512, XP-13512 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

gabapentin enacarbil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS
Objective: To assess the efficacy and tolerability of the nondopaminergic agent XP13512/GSK1838262 in adults with moderate to… 
Highly Cited
2009
Highly Cited
2009
A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.
STUDY OBJECTIVE To evaluate the efficacy and tolerability of XP13512/ GSK1838262, an investigational nondopaminergic agent for… 
Review
2008
Review
2008
Modifications of Antiepileptic Drugs for Improved Tolerability and Efficacy
Introduction A large number of antiepileptic drugs (AEDs) are available today, but they may not be satisfactory regarding… 
Review
2006
Review
2006
New antiepileptic drugs that are second generation to existing antiepileptic drugs
In the last decade, 10 new antiepileptic drugs (AEDs) have been introduced that offer appreciable advantages in terms of their… 
2005
2005
XP 13512 beneficial in RLS
  • 2005
  • Corpus ID: 195146005
2005
2005
XP 13512 may reduce postherpetic pain
  • 2005
  • Corpus ID: 195153913
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)